Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients

Autor: Bakr, Salwa, Salem, Karem Mohamed, Rashed, Ahmed Mohammed, Tantawy, Mohamed E A, Elsary, Asmaa Younis, Shamardl, Hanan Abdelmoneam, Ezzat, Eman Mahmoud
Zdroj: In Hematology, Transfusion and Cell Therapy November 2024 46 Supplement 5:S214-S222
Databáze: ScienceDirect